(11/6/10)  I have placed a strong buy at 20 cents. The fundamentals of the financial statements have improved.  I am also considering that this stock has a wide price range every 12 to 14 months.  My ongoing comments will be placed at www.copytele.net for paid members of the stockholder's forum.

(9/7/10)  COPY has remained at the 20 cent level for a while now.  However, this stock has a record of attaining a certain range each and every year.  You can see this from its chart.  It always seems to range from some low level all the way to the one dollar level.  I happen to believe that there is a reason for this.  I do believe that there is a deviant force of certain parties which cannot be proven which acts upon the price.  Someone is making money each year on that price range.  Buy and hold for that next trip to the 90 cent to one dollar level.

CopyTele has remained at levels between 20 cents and one dollar for a very long time.  At the lower levels, COPY remains a longer term investment with potential without very much probability of going bankrupt.  Despite the restricted range of trading, it does have products that could be of great value.  The COPY chart does clearly show that it can range easily year after year from low levels to the one dollar level.  It simply does not make sense to sell at levels below 50 or 60 cents.  Note:  (7/6/09) CopyTele remains a buy without reservation at levels below .38.  When the world economy improves, a realistic price objective is above the $2 level.

 

(10/10/10)  Holliday of BAC has just bought 30,000 more shares.  This is a bullish sign.  BAC remains a buy at these low levels of 12 to 13.

JAN 20:  BAC is raised to outperform by Oppenheimer.  One by one, BAC is being raised by the big brokerage houses.  Soon, all of the major funds will be buying this stock.

 

 

 

Can Ford survive as GM goes under?  As GM and Chrysler is destroyed from within, Ford becomes the beneficiary of the whole American auto industry.  Ford is now projecting some very promising numbers.  People that would buy GM or Chrysler products will now turn to Ford.  It does not end there.  Ford has the Fusion model which is powered by a battery driven engine that is clearly outperforning the Japanese.  GM and Chrysler failed to accomplish this when they had the chance. 

 

(March 30, 2010)  News Release

 

(MAR 25, 2010)  The following news release was done concerning government owned shares.

Citigroup ($4.27, +$0.12, +2.89%) said it plans to participate in the second-mortgage modification program as part of the government's Home Affordable Mortgage Program, providing additional help to struggling homeowners. Meanwhile, the Treasury Department is nearing a plan to sell its 27% stake in Citigroup, which would utilize a pre-set trading schedule to sell the shares by the end of the year, Bloomberg News reported Thursday on its Web site, citing people with direct knowledge of the matter.

(MAR 23,2010)  This stock is very cheap.  There is evidence that people like Soros have bought into this issue.  It is still being backed by some government ownership but soon it will be free and clear.  Profit margins are continuing to improve.  At this 4 level it is a buy for the longer term.

 

(FEB 22, 2011)  The market performance has been a big disappointment.  However, it must be noted that drug stocks thrive on constant news.  That has been the problem.  However, the company is pushing the FDA to advance the Celldex program on brain cancer.  Something may occur next month in that regard.

CLDX:  Celldex Therapeutics

(May 21, 2010)   This is drug company that has developed a vaccine for brain cancer and is going into the last stages of final approval.   It has just dropped into a good price range of 6 to 7 from recent highs on the current market decline.

 

(FEB 22, 2011)  MELI is still good for much higher prices.  If you bought it when it was first entered here.  Keep it.

(comment made about 2 years ago) MercadoLibre is simply a long term investment with plenty of upside potential in a growing industry.